Doctor’s lung-cancer journey shows treatment progress and access barriers

Stanford physician Bryant Lin tells NPR how targeted lung-cancer treatments have extended his life while insurance delays and changing drug responses complicate care. His latest scans showed progression, prompting consideration of another treatment or a trial. The profile illustrates both the promise and limits of personalized medicine; one patient’s experience cannot predict another’s outcome.